Interleukin-1 receptor antagonist: a sensitive marker of instability in patients with coronary artery disease.
- 1 January 2002
- journal article
- research article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 14 (2) , 139-143
- https://doi.org/10.1023/a:1023284912712
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Inflammatory markers and coronary interventions: A potentially useful follow-up modality after stentingCatheterization and Cardiovascular Interventions, 2002
- Inflammatory markers of ischemic coronary syndromes.2001
- Modulation of the acute phase response by altered expression of the IL-1 type 1 receptor or IL-1raAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2000
- Arterial Inflammation in Mice Lacking the Interleukin 1 Receptor Antagonist GeneThe Journal of Experimental Medicine, 2000
- Increasing Levels of Interleukin (IL)-1Ra and IL-6 During the First 2 Days of Hospitalization in Unstable Angina Are Associated With Increased Risk of In-Hospital Coronary EventsCirculation, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Production of C-reactive protein and risk of coronary events in stable and unstable anginaThe Lancet, 1997
- Biologic basis for interleukin-1 in diseaseBlood, 1996
- Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapyAmerican Heart Journal, 1995
- Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease.1992